Silvana Pilotti

Active 1978–2020

96
Papers
18,233
Citations
82
h-index
96
i10-index

Citations

Citations per year for Silvana Pilotti1980: 1 citations1981: 2 citations1982: 2 citations1983: 4 citations1984: 5 citations1985: 3 citations1986: 4 citations1987: 4 citations1988: 4 citations1989: 1 citations1990: 2 citations1991: 3 citations1992: 6 citations1993: 3 citations1994: 5 citations1995: 16 citations1996: 23 citations1997: 36 citations1998: 47 citations1999: 49 citations2000: 77 citations2001: 82 citations2002: 93 citations2003: 91 citations2004: 78 citations2005: 112 citations2006: 176 citations2007: 196 citations2008: 206 citations2009: 207 citations2010: 271 citations2011: 210 citations2012: 178 citations2013: 176 citations2014: 154 citations2015: 166 citations2016: 157 citations2017: 169 citations2018: 130 citations2019: 397 citations2020: 441 citations2021: 410 citations2022: 263 citations2023: 158 citations2024: 250 citations2025: 97 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,033 citing papers, 27.1% of this breakdownItaly: 810 citing papers, 10.8% of this breakdownChina: 601 citing papers, 8% of this breakdownUnited Kingdom: 459 citing papers, 6.1% of this breakdownGermany: 362 citing papers, 4.8% of this breakdownFrance: 333 citing papers, 4.4% of this breakdownCanada: 246 citing papers, 3.3% of this breakdownSpain: 237 citing papers, 3.2% of this breakdownJapan: 220 citing papers, 2.9% of this breakdownNetherlands: 210 citing papers, 2.8% of this breakdownAustralia: 181 citing papers, 2.4% of this breakdownSwitzerland: 131 citing papers, 1.7% of this breakdown
0%27.1%Other 22.5%

Fields

  • Medicine61.6%
  • Biochemistry, Genetics and Molecular Biology25.9%
  • Immunology and Microbiology10.4%
  • Engineering0.5%
  • Neuroscience0.3%
  • Computer Science0.3%
  • Other1%

Topics

  • Sarcoma Diagnosis and Treatment4.9%
  • Cancer Cells and Metastasis4.3%
  • Immune cells in cancer3.3%
  • Thyroid Cancer Diagnosis and Treatment2.5%
  • Cancer-related Molecular Pathways2.2%
  • Head and Neck Cancer Studies1.9%
  • Other80.9%

Coauthors

All papers

Open in search
  1. Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2013 cited by 862

  2. Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cell 2019 cited by 257

  3. Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties

    Authors: , , , , , , , , - Cancer Research 2005 cited by 1,723

  4. Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma

    Authors: , , , , , - Oncotarget 2016 cited by 169

  5. Malignant peripheral nerve sheath tumors

    Authors: , , , , , , , , , , , - Cancer 2006 cited by 440

  6. Chordoma of the Mobile Spine and Sacrum: A Retrospective Analysis of a Series of Patients Surgically Treated at Two Referral Centers

    Authors: , , , , , , , , , , - Annals of Surgical Oncology 2009 cited by 193

  7. Myogenic Differentiation and Histologic Grading Are Major Prognostic Determinants in Retroperitoneal Liposarcoma

    Authors: , , , , , , , , , , , , , , - The American Journal of Surgical Pathology 2015 cited by 131

  8. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2007 cited by 449

  9. Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Research 2010 cited by 263

  10. Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab

    Authors: , , , , , , , , , , , , , , - Clinical Cancer Research 2016 cited by 96

  11. Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome

    Authors: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2016 cited by 90

  12. Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jocelyne Jacquemier, Teresa Wagner, Julian Peto, Michael R. Stratton, Lesley McGuffog, Douglas F. Easton - Clinical Cancer Research 2005 cited by 606

  13. SMARCB1/INI1 Tumor Suppressor Gene Is Frequently Inactivated in Epithelioid Sarcomas

    Authors: , , , , , , - Cancer Research 2005 cited by 335

  14. TP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma

    Authors: , , , , , , , - Journal of Clinical Oncology 2010 cited by 151

  15. Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas

    Authors: , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 cited by 22

  16. Phase II Study of Imatinib in Advanced Chordoma

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 cited by 271

  17. Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor–positive salivary gland cancers

    Authors: , , , , , , , , , , , , - Head & Neck 2014 cited by 126

  18. MIF/CD74 axis is a target for novel therapies in colon carcinomatosis

    Authors: , , , , , , , , , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2017 cited by 76

  19. Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , - Cancers 2020 cited by 56

  20. High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2006 cited by 659

  21. Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene

    Authors: , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 329

  22. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis

    Authors: , , , , , , , , , , - Cancer 2001 cited by 255

  23. A Randomized Trial Comparing Axillary Dissection to No Axillary Dissection in Older Patients With T1N0 Breast Cancer

    Authors: , , , , , , , - Annals of Surgery 2005 cited by 199

  24. A novel zinc finger gene is fused to EWS in small round cell tumor

    Authors: , , , , , , , , , , , - Oncogene 2000 cited by 191